Outi Äyräs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Outi Äyräs has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Jorma Paavonen
Faculty of Medicine, University of Helsinki, Helsinki, Finland
5 shared publications - Päivi Rahkola-Soisalo
Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki University, Helsinki, Finland
4 shared publications - Hilde Marie Engjom
Department of Health Promotion, Division Public Health and Prevention, Norwegian Institute of Public Health, Zander Kaaesgate 7, 5015 Bergen
3 shared publications Minna Tikkanen
Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
3 shared publications- Teresia Svanvik
Institute of Clinical Sciences, Department of Obstetrics and Gynaecology University of Gothenburg Gothenburg Sweden
3 shared publications - Anna Juliane Marsian Aabakke
Department of Obstetrics and Gynecology Copenhagen University Hospital‐Holbæk Holbæk Denmark
2 shared publications
Latest Publications
- Open Access
- 21 February 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (6) , 1063-1072
Early suppression policies protected pregnant women from COVID‐19 in 2020: A population‐based surveillance from the Nordic countries
Introduction: The Coronavirus 2019 Disease (COVID‐19) pandemic reached the Nordic countries in March 2020. Public health interventions to limit viral transmission varied across different countries both in timing and in magnitude. Interventions indicated by an Oxford Stringency Index ≥50 were implemented early (March 13–17, 2020) in Denmark, Finland, Norway and Iceland, and on March 26, 2020 in Sweden. The aim of the current study was to assess the incidence of COVID‐19‐related admissions of pregnant women in the Nordic countries in relation to the different national public health strategies during the first year of the pandemic.Material and methods: This is a meta‐analysis of population‐based cohort studies in the five Nordic countries with national or regional surveillance in the Nordic Obstetric Surveillance System (NOSS) collaboration: national data from Denmark, Finland, Iceland and Norway, and regional data covering 31% of births in Sweden. The source population consisted of women giving birth in the included areas March 1–December 31, 2020. Pregnant women with a positive SARS‐CoV‐2 PCR test ≤14 days before hospital admission were included, and admissions were stratified as either COVID‐19‐related or non‐COVID (other obstetric healthcare). Information about public health policies was retrieved retrospectively.Results: In total, 392 382 maternities were considered. Of these, 600 women were diagnosed with SARS‐CoV‐2 infection and 137 (22.8%) were admitted for COVID‐19 symptoms. The pooled incidence of COVID‐19 admissions per 1000 maternities was 0.5 (95% confidence interval [CI] 0.2 to 1.2, I2 = 77.6, tau2 = 0.68, P = 0.0), ranging from no admissions in Iceland to 1.9 admissions in the Swedish regions. Interventions to restrict viral transmission were less stringent in Sweden than in the other Nordic countries.Conclusions: There was a clear variation in pregnant women's risk of COVID‐19 admission across countries with similar healthcare systems but different public health interventions to limit viral transmission. The meta‐analysis indicates that early suppression policies protected pregnant women from severe COVID‐19 disease prior to the availability of individual protection with vaccines.
- 21 February 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (6) , 1063-1072
Open AccessEarly suppression policies protected pregnant women from COVID‐19 in 2020: A population‐based surveillance from the Nordic countries
Introduction: The Coronavirus 2019 Disease (COVID‐19) pandemic reached the Nordic countries in March 2020. Public health interventions to limit viral transmission varied across different countries both in timing and in magnitude. Interventions indicated by an Oxford Stringency Index ≥50 were implemented early (March 13–17, 2020) in Denmark, Finland, Norway and Iceland, and on March 26, 2020 in Sweden. The aim of the current study was to assess the incidence of COVID‐19‐related admissions of pregnant women in the Nordic countries in relation to the different national public health strategies during the first year of the pandemic.Material and methods: This is a meta‐analysis of population‐based cohort studies in the five Nordic countries with national or regional surveillance in the Nordic Obstetric Surveillance System (NOSS) collaboration: national data from Denmark, Finland, Iceland and Norway, and regional data covering 31% of births in Sweden. The source population consisted of women giving birth in the included areas March 1–December 31, 2020. Pregnant women with a positive SARS‐CoV‐2 PCR test ≤14 days before hospital admission were included, and admissions were stratified as either COVID‐19‐related or non‐COVID (other obstetric healthcare). Information about public health policies was retrieved retrospectively.Results: In total, 392 382 maternities were considered. Of these, 600 women were diagnosed with SARS‐CoV‐2 infection and 137 (22.8%) were admitted for COVID‐19 symptoms. The pooled incidence of COVID‐19 admissions per 1000 maternities was 0.5 (95% confidence interval [CI] 0.2 to 1.2, I2 = 77.6, tau2 = 0.68, P = 0.0), ranging from no admissions in Iceland to 1.9 admissions in the Swedish regions. Interventions to restrict viral transmission were less stringent in Sweden than in the other Nordic countries.Conclusions: There was a clear variation in pregnant women's risk of COVID‐19 admission across countries with similar healthcare systems but different public health interventions to limit viral transmission. The meta‐analysis indicates that early suppression policies protected pregnant women from severe COVID‐19 disease prior to the availability of individual protection with vaccines.
- Open Access
- 18 August 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (11) , 1521-1530
Variations across Europe in hospitalization and management of pregnant women with SARS‐CoV‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems (INOSS)
Introduction: The majority of data on COVID‐19 in pregnancy are not from sound population‐based active surveillance systems.Material and methods: We conducted a multi‐national study of population‐based national or regional prospective cohorts using standardized definitions within the International Network of Obstetric Survey systems (INOSS). From a source population of women giving birth between March 1 and August 31, 2020, we included pregnant women admitted to hospital with a positive SARS‐CoV‐2 PCR test ≤7 days prior to or during admission and up to 2 days after birth. The admissions were further categorized as COVID‐19‐related or non‐COVID‐19‐related. The primary outcome of interest was incidence of COVID‐19‐related hospital admission. Secondary outcomes included severe maternal disease (ICU admission and mechanical ventilation) and COVID‐19‐directed medical treatment.Results: In a source population of 816 628 maternities, a total of 2338 pregnant women were admitted with SARS‐CoV‐2; among them 940 (40%) were COVID‐19‐related admissions. The pooled incidence estimate for COVID‐19‐related admission was 0.59 (95% confidence interval 0.27–1.02) per 1000 maternities, with notable heterogeneity across countries (I2 = 97.3%, P = 0.00). In the COVID‐19 admission group, between 8% and 17% of the women were admitted to intensive care, and 5%–13% needed mechanical ventilation. Thromboprophylaxis was the most frequent treatment given during COVID‐19‐related admission (range 14%–55%). Among 908 infants born to women in the COVID‐19‐related admission group, 5 (0.6%) stillbirths were reported.Conclusions: During the initial months of the pandemic, we found substantial variations in incidence of COVID‐19‐related admissions in nine European countries. Few pregnant women received COVID‐19‐directed medical treatment. Several barriers to rapid surveillance were identified. Investment in robust surveillance should be prioritized to prepare for future pandemics.
- 18 August 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (11) , 1521-1530
Open AccessVariations across Europe in hospitalization and management of pregnant women with SARS‐CoV‐2 during the initial phase of the pandemic: Multi‐national population‐based cohort study using the International Network of Obstetric Survey Systems (INOSS)
Introduction: The majority of data on COVID‐19 in pregnancy are not from sound population‐based active surveillance systems.Material and methods: We conducted a multi‐national study of population‐based national or regional prospective cohorts using standardized definitions within the International Network of Obstetric Survey systems (INOSS). From a source population of women giving birth between March 1 and August 31, 2020, we included pregnant women admitted to hospital with a positive SARS‐CoV‐2 PCR test ≤7 days prior to or during admission and up to 2 days after birth. The admissions were further categorized as COVID‐19‐related or non‐COVID‐19‐related. The primary outcome of interest was incidence of COVID‐19‐related hospital admission. Secondary outcomes included severe maternal disease (ICU admission and mechanical ventilation) and COVID‐19‐directed medical treatment.Results: In a source population of 816 628 maternities, a total of 2338 pregnant women were admitted with SARS‐CoV‐2; among them 940 (40%) were COVID‐19‐related admissions. The pooled incidence estimate for COVID‐19‐related admission was 0.59 (95% confidence interval 0.27–1.02) per 1000 maternities, with notable heterogeneity across countries (I2 = 97.3%, P = 0.00). In the COVID‐19 admission group, between 8% and 17% of the women were admitted to intensive care, and 5%–13% needed mechanical ventilation. Thromboprophylaxis was the most frequent treatment given during COVID‐19‐related admission (range 14%–55%). Among 908 infants born to women in the COVID‐19‐related admission group, 5 (0.6%) stillbirths were reported.Conclusions: During the initial months of the pandemic, we found substantial variations in incidence of COVID‐19‐related admissions in nine European countries. Few pregnant women received COVID‐19‐directed medical treatment. Several barriers to rapid surveillance were identified. Investment in robust surveillance should be prioritized to prepare for future pandemics.
- 1 June 2019
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 237, 117-120
High risk in the first-trimester combined screening: Long-term outcomes of the children
- 1 June 2019
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 237, 117-120
High risk in the first-trimester combined screening: Long-term outcomes of the children
- 25 February 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (5) , 541-546
Long‐term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening
Introduction: Increased nuchal translucency is known to be associated with chromosomal and structural defects and genetic syndromes. Little is known about the overall long‐term outcome of euploid children after increased nuchal translucency. The aims of this study were to assess the additional structural defects diagnosed after discharge from the delivery hospital and the long‐term overall outcome of euploid children after increased nuchal translucency and normal second trimester anomaly scan.Material and methods: All children from singleton euploid pregnancies during 2002–2007 with increased nuchal translucency in the first trimester screening, normal second trimester anomaly scan, and discharged as apparently healthy were included. Data on the structural defects and genetic disorders diagnosed until 2012 were retrieved from hospital databases and national registers. Previously published data of structural defects diagnosed after birth but before discharge and of severe neurodevelopmental impairment and genetic syndromes was added.Results: The cohort included 733 children. During the follow‐up time (mean 6.5 years), major structural defects were observed in 10 (1.4%), genetic disorders in two (0.3%), and minor defects in 23 (3.1%) children. In addition, there were 42 previously published major structural defects and major neurodevelopmental impairment or genetic disorders. Adding these results together, major health problems were detected in 54 (7%) euploid children with increased fetal nuchal translucency and normal findings in second trimester anomaly scan.Conclusion: Although only few additional major structural defects are diagnosed during the follow‐up after increased fetal nuchal translucency, 7% of fetuses assumed to be healthy after second trimester anomaly scan have a major health impairment.
- 25 February 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (5) , 541-546
Long‐term outcome in apparently healthy children with increased nuchal translucency in the first trimester screening
Introduction: Increased nuchal translucency is known to be associated with chromosomal and structural defects and genetic syndromes. Little is known about the overall long‐term outcome of euploid children after increased nuchal translucency. The aims of this study were to assess the additional structural defects diagnosed after discharge from the delivery hospital and the long‐term overall outcome of euploid children after increased nuchal translucency and normal second trimester anomaly scan.Material and methods: All children from singleton euploid pregnancies during 2002–2007 with increased nuchal translucency in the first trimester screening, normal second trimester anomaly scan, and discharged as apparently healthy were included. Data on the structural defects and genetic disorders diagnosed until 2012 were retrieved from hospital databases and national registers. Previously published data of structural defects diagnosed after birth but before discharge and of severe neurodevelopmental impairment and genetic syndromes was added.Results: The cohort included 733 children. During the follow‐up time (mean 6.5 years), major structural defects were observed in 10 (1.4%), genetic disorders in two (0.3%), and minor defects in 23 (3.1%) children. In addition, there were 42 previously published major structural defects and major neurodevelopmental impairment or genetic disorders. Adding these results together, major health problems were detected in 54 (7%) euploid children with increased fetal nuchal translucency and normal findings in second trimester anomaly scan.Conclusion: Although only few additional major structural defects are diagnosed during the follow‐up after increased fetal nuchal translucency, 7% of fetuses assumed to be healthy after second trimester anomaly scan have a major health impairment.
- 10 June 2015
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (9) , 901-905
The significance of gender in fetuses with increased nuchal translucency: pregnancy outcomes and long‐term outcomes of children
Objective: We aim to study the gender impact on the pregnancy outcome and on the long‐term outcome of children after increased fetal nuchal translucency.Method: All singleton pregnancies with increased nuchal translucency (≥3 mm until 1 March 2004 and ≥95th percentile thereafter) referred to Helsinki University Hospital from 2002 to 2007 with known gender and normal sex chromosomes were included. The pregnancy outcome (miscarriage, termination of pregnancy, perinatal death or delivery of a healthy/unhealthy child) and the long‐term outcome (structural defects or neurodevelopmental impairment) were recorded from hospital databases and national registers.Results: Of the 1011 fetuses, 600 were male and 411 were female, male‐to‐female ratio being 1.46 : 1. This ratio decreased by increasing NT thickness, being 1 : 1 when the NT was ≥4.0 mm. The pregnancy outcome was better among male fetuses than among female fetuses (p = 0.049). There were more chromosomal abnormalities among the females than the males (p = 0.04). Among euploid fetuses, the pregnancy outcome and the long‐term outcome were equal.Conclusion: After increased nuchal translucency, the pregnancy outcome of male fetuses was better due to the lower incidence of chromosomal abnormalities compared with female fetuses. Among euploid fetuses, the pregnancy outcome and the long‐term outcome were equal. © 2015 John Wiley & Sons, Ltd.
- 10 June 2015
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (9) , 901-905
The significance of gender in fetuses with increased nuchal translucency: pregnancy outcomes and long‐term outcomes of children
Objective: We aim to study the gender impact on the pregnancy outcome and on the long‐term outcome of children after increased fetal nuchal translucency.Method: All singleton pregnancies with increased nuchal translucency (≥3 mm until 1 March 2004 and ≥95th percentile thereafter) referred to Helsinki University Hospital from 2002 to 2007 with known gender and normal sex chromosomes were included. The pregnancy outcome (miscarriage, termination of pregnancy, perinatal death or delivery of a healthy/unhealthy child) and the long‐term outcome (structural defects or neurodevelopmental impairment) were recorded from hospital databases and national registers.Results: Of the 1011 fetuses, 600 were male and 411 were female, male‐to‐female ratio being 1.46 : 1. This ratio decreased by increasing NT thickness, being 1 : 1 when the NT was ≥4.0 mm. The pregnancy outcome was better among male fetuses than among female fetuses (p = 0.049). There were more chromosomal abnormalities among the females than the males (p = 0.04). Among euploid fetuses, the pregnancy outcome and the long‐term outcome were equal.Conclusion: After increased nuchal translucency, the pregnancy outcome of male fetuses was better due to the lower incidence of chromosomal abnormalities compared with female fetuses. Among euploid fetuses, the pregnancy outcome and the long‐term outcome were equal. © 2015 John Wiley & Sons, Ltd.
- Open Access
- 15 December 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (4) , 362-369
Long‐term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening
Objective: To assess the long‐term neurodevelopmental outcome of children born from singleton euploid pregnancies with increased fetal nuchal translucency (NT) in the first trimester ultrasound screening and without structural anomalies in the second trimester ultrasound screening.Study Design: This is a register‐based retrospective cohort study carried out at a tertiary referral centre from 2002 to 2007. Children were followed up until 2012. All fetuses had increased NT (>95th percentile) at the first trimester ultrasound screening and normal findings in the second trimester ultrasound screening. Data about the neurodevelopmental outcome was retrieved from the hospital databases, The National Institute for Health and Welfare, and the Finnish Causes of Death Statistics Database. Information about received disability allowances was gathered from the Social Insurance Institute of Finland.Results: The study population consists of 691 children. The mean follow‐up time was 6.5 years. Neurodevelopmental disorders occurred in 29 children (4.2%). Twelve of these 29 children (1.7%) had severe neurodevelopmental impairment.Conclusions: The long‐term neurodevelopmental outcome of children after increased fetal NT is reassuring. This information should be added to the parental counselling of such cases. © 2014 John Wiley & Sons, Ltd.
- 15 December 2014
- Published by Wiley in Prenatal Diagnosis
- Vol. 35 (4) , 362-369
Open AccessLong‐term neurodevelopmental outcome of children from euploid pregnancies with increased nuchal translucency in the first trimester screening
Objective: To assess the long‐term neurodevelopmental outcome of children born from singleton euploid pregnancies with increased fetal nuchal translucency (NT) in the first trimester ultrasound screening and without structural anomalies in the second trimester ultrasound screening.Study Design: This is a register‐based retrospective cohort study carried out at a tertiary referral centre from 2002 to 2007. Children were followed up until 2012. All fetuses had increased NT (>95th percentile) at the first trimester ultrasound screening and normal findings in the second trimester ultrasound screening. Data about the neurodevelopmental outcome was retrieved from the hospital databases, The National Institute for Health and Welfare, and the Finnish Causes of Death Statistics Database. Information about received disability allowances was gathered from the Social Insurance Institute of Finland.Results: The study population consists of 691 children. The mean follow‐up time was 6.5 years. Neurodevelopmental disorders occurred in 29 children (4.2%). Twelve of these 29 children (1.7%) had severe neurodevelopmental impairment.Conclusions: The long‐term neurodevelopmental outcome of children after increased fetal NT is reassuring. This information should be added to the parental counselling of such cases. © 2014 John Wiley & Sons, Ltd.
- 23 April 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (9) , 856-862
Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution
Objectives: The goals of this study are to assess pregnancy outcome with increased nuchal translucency (NT) and to determine the risk of adverse pregnancy outcome in relation to the degree of increased NT.Methods: All singleton pregnancies with increased NT at the first screening ultrasound examination referred to the Department of Fetal Medicine at the Helsinki University Central Hospital during 2002 to 2007 were included. Pregnancy outcomes and short‐term outcomes of the newborns were recorded and analyzed.Results: Of the 1063 pregnancies, karyotype was normal in 834 (78%). The majority, 611 (73%), of euploid fetuses was in the lowest NT group (95th percentile – 3.4 mm). Percentage of favorable outcome decreased from 92% in the lowest NT group (95th percentile – 3.4 mm) to 18% in the highest NT group (≥6.5 mm). Structural defects or genetic disorders were observed in 74 (9%) of cases with normal karyotype, of which 43 (58%) resulted in live birth, 25 (34%) in termination of pregnancy, and 6 (8%) in miscarriage or perinatal death.Conclusions: Even minimal (95th percentile – 3.4 mm) increase in NT thickness is associated with adverse pregnancy outcome also in euploid fetuses. © 2013 John Wiley & Sons, Ltd.
- 23 April 2013
- Published by Wiley in Prenatal Diagnosis
- Vol. 33 (9) , 856-862
Increased nuchal translucency and pregnancy outcome: a retrospective study of 1063 consecutive singleton pregnancies in a single referral institution
Objectives: The goals of this study are to assess pregnancy outcome with increased nuchal translucency (NT) and to determine the risk of adverse pregnancy outcome in relation to the degree of increased NT.Methods: All singleton pregnancies with increased NT at the first screening ultrasound examination referred to the Department of Fetal Medicine at the Helsinki University Central Hospital during 2002 to 2007 were included. Pregnancy outcomes and short‐term outcomes of the newborns were recorded and analyzed.Results: Of the 1063 pregnancies, karyotype was normal in 834 (78%). The majority, 611 (73%), of euploid fetuses was in the lowest NT group (95th percentile – 3.4 mm). Percentage of favorable outcome decreased from 92% in the lowest NT group (95th percentile – 3.4 mm) to 18% in the highest NT group (≥6.5 mm). Structural defects or genetic disorders were observed in 74 (9%) of cases with normal karyotype, of which 43 (58%) resulted in live birth, 25 (34%) in termination of pregnancy, and 6 (8%) in miscarriage or perinatal death.Conclusions: Even minimal (95th percentile – 3.4 mm) increase in NT thickness is associated with adverse pregnancy outcome also in euploid fetuses. © 2013 John Wiley & Sons, Ltd.